Over past few years, a significant interest has been observed in new applications of plasma-liquid interactions (PLIs), particularly in relation to their usage in environmental engineering, microbiology, analytical chemistry, and nanotechnology. The use of large quantities of nanomaterials, es
At a wastewater treatment plant in Dekalb County, Georgia, progressing cavity pumps gave dry running problems and consequential high maintenance costs when dosing flocculent.
The Polymer medium was described as a ‘High Charge Cationic Emulsion (trade name of Clarifloc SE1080)’
Explosion-proof Peristaltic Pumps Market as well as a variety of aspects specific to the sector, including market size, development status, business trends, and forecast. The report also provides a brief summary of the competitors’ businesses as well as their distinct growth opportunitie
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Rating) Director Bertrand Loy purchased 9,291 shares of the company's stock in a transaction dated Friday, August 26th. The shares were bought at an
September 01, 2022 09:10 ET | Source: CMI CMI
Seattle, Sept. 01, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights’ analys
Falmouth, UK, 24th August 2022 / Sciad Newswire / Aseptic fill/finish experts Flexicon Liquid Filling, part of Watson-Marlow Fluid Technology Solutions (WMFTS), and barrier technology specialists Franz Ziel GmbH, today announce the launch of Cellefill™ —&
August 08, 2022 08:23 ET | Source: Research and Markets Research and Markets
Dublin, Aug. 08, 2022 (GLOBE NEWSWIRE) -- The "Global Meteri
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Avantor, Inc. (NYSE:AVTR - Get Rating) was the target of a significant drop in short interest in July. As of July 31st, there was short interest totalling 8,700,000 shares, a drop of 13.2% from
Permanent link to this press release:
Delete press release Edit press rele
New drug development is today focused largely on biopharmaceuticals rather than chemicals, which means that the resultant drugs tend to be injectable liquids instead of solids. Furthermore, the new drugs are typically designed for specific populations, hence batch sizes are smaller. Alongsi